Eddit
Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
*'''[[Further reading]]''' | *'''[[Further reading]]''' | ||
+ | {{tp|p=32327431|t=2020. Keeping up with studies on covid-19: systematic search strategies and resources |pdf=|usr=}} | ||
+ | |||
*'''[[Unproven ideas]]''' | *'''[[Unproven ideas]]''' | ||
Zeile 7: | Zeile 9: | ||
{{tp|p=32196678|t=ä. Eleven faces of coronavirus disease 2019 |pdf=|usr=}} | {{tp|p=32196678|t=ä. Eleven faces of coronavirus disease 2019 |pdf=|usr=}} | ||
{{tp|p=32363707|t=2020. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review |pdf=|usr=}} | {{tp|p=32363707|t=2020. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review |pdf=|usr=}} | ||
− | + | {{tp|p=32253003|t=2020. COVID-19 virus and children: What do we know?|pdf=|usr=}} | |
*'''[[Clinical guidelines and advice]]''' | *'''[[Clinical guidelines and advice]]''' | ||
Zeile 21: | Zeile 23: | ||
{{tp|p=32341294|t=2020. Toward Precision Delivery of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Cardiorespiratory Failure |pdf=|usr=}} | {{tp|p=32341294|t=2020. Toward Precision Delivery of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Cardiorespiratory Failure |pdf=|usr=}} | ||
{{tp|p=32317557|t=2020. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients |pdf=|usr=}} | {{tp|p=32317557|t=2020. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients |pdf=|usr=}} | ||
− | + | {{tp|p=32243267|t=2020. Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure |pdf=|usr=}} | |
− | + | {{tp|p=32243266|t=2020. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China |pdf=|usr=}} | |
+ | {{tp|p=32366375|t=2020. Management of respiratory failure due to covid-19 |pdf=|usr=}} | ||
+ | {{tp|p=32229575|t=2020. Covid-19: Mercedes F1 to provide breathing aid as alternative to ventilator |pdf=|usr=}} | ||
+ | {{tp|p=32377387|t=2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19 |pdf=|usr=}} | ||
*'''[[Diagnosis (Laboratory)]]''' | *'''[[Diagnosis (Laboratory)]]''' | ||
{{tp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}} | {{tp|p=32293905|t=2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients |pdf=|usr=}} | ||
− | + | {{tp|p=32338536|t=2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR) |pdf=|usr=}} | |
− | + | {{tp|p=32294808|t=2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology) |pdf=|usr=}} | |
*'''[[Diagnosis (Lung CT, Sonography)]]''' | *'''[[Diagnosis (Lung CT, Sonography)]]''' | ||
Zeile 47: | Zeile 52: | ||
*'''[[Target binding and uptake]]''' | *'''[[Target binding and uptake]]''' | ||
{{tp|p=32369402|t=2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2) |pdf=|usr=}} | {{tp|p=32369402|t=2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2) |pdf=|usr=}} | ||
− | + | {{tp|p=32378705|t=2020. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity |pdf=|usr=}} | |
*'''[[Cytopathic effects]]''' | *'''[[Cytopathic effects]]''' | ||
Zeile 59: | Zeile 64: | ||
*'''[[Immunology]]''' | *'''[[Immunology]]''' | ||
{{ttp|p=32376393|t=ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |pdf=|usr=}} | {{ttp|p=32376393|t=ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |pdf=|usr=}} | ||
+ | {{tp|p=32220633|t=2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?|pdf=|usr=}} | ||
+ | |||
*'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | ||
{{ttp|p=32376400|t=ä. Cytokine storm syndrome in severe COVID-19 |pdf=|usr=}} | {{ttp|p=32376400|t=ä. Cytokine storm syndrome in severe COVID-19 |pdf=|usr=}} | ||
{{ttp|p=32376401|t=ä. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?|pdf=|usr=}} | {{ttp|p=32376401|t=ä. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH?|pdf=|usr=}} | ||
+ | {{tp|p=32293098|t=2020. On the Alert for Cytokine Storm: Immunopathology in COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32339387|t=2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin |pdf=|usr=}} | ||
+ | {{tp|p=32345602|t=2020. Covid-19: concerns grow over inflammatory syndrome emerging in children |pdf=|usr=}} | ||
+ | |||
+ | |||
---- | ---- | ||
Zeile 75: | Zeile 87: | ||
*'''[[Similar diseases and pathomechanisms]]''' | *'''[[Similar diseases and pathomechanisms]]''' | ||
{{tp|p=32348692|t=2020. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids |pdf=|usr=}} | {{tp|p=32348692|t=2020. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids |pdf=|usr=}} | ||
+ | {{tp|p=32374218|t=2020. Avian coronaviruses |pdf=|usr=}} | ||
+ | |||
+ | |||
---- | ---- | ||
Zeile 86: | Zeile 101: | ||
{{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | {{tp|p=32173883|t=ä. COVID?19 and mycoplasma pneumoniae coinfection |pdf=|usr=}} | ||
{{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | {{tp|p=32314699|t=2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32271596|t=2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran |pdf=|usr=}} | ||
+ | {{ttp|p=32374823|t=2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |pdf=|usr=}} | ||
*'''[[ARDS]]''' | *'''[[ARDS]]''' | ||
*'''[[Pulmonary embolism, coagulation]]''' | *'''[[Pulmonary embolism, coagulation]]''' | ||
+ | {{tp|p=32339221|t=2020. COVID-19 and its implications for thrombosis and anticoagulation |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Hematology]]''' | *'''[[Hematology]]''' | ||
Zeile 107: | Zeile 127: | ||
*'''[[Gastroenterology, hepatology]]''' | *'''[[Gastroenterology, hepatology]]''' | ||
{{tp|p=32374032|t=2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |pdf=|usr=}} | {{tp|p=32374032|t=2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors |pdf=|usr=}} | ||
− | + | {{tp|p=32302212|t=2020. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation |pdf=|usr=}} | |
Zeile 129: | Zeile 149: | ||
{{tp|p=32312768|t=2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia |pdf=|usr=}} | {{tp|p=32312768|t=2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia |pdf=|usr=}} | ||
{{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}} | {{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}} | ||
− | + | {{tp|p=32180426|t=2020. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes |pdf=|usr=}} | |
+ | {{tp|p=32255510|t=2020. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement |pdf=|usr=}} | ||
+ | {{tp|p=32369656|t=2020. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding |pdf=|usr=}} | ||
+ | {{tp|p=32219995|t=2020. Safe delivery for pregnancies affected by COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32339382|t=2020. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis |pdf=|usr=}} | ||
+ | {{tp|p=32324956|t=2020. How should we treat pregnant women infected with SARS-CoV-2?|pdf=|usr=}} | ||
+ | {{tp|p=32340018|t=2020. Coronavirus Disease 2019 in a Hemodialysis Patient |pdf=|usr=}} | ||
+ | {{tp|p=32220865|t=2020. Non-steroidal anti-inflammatory drugs and covid-19 |pdf=|usr=}} | ||
+ | {{tp|p=32205306|t=2020. Covid-19: European drugs agency to review safety of ibuprofen |pdf=|usr=}} | ||
+ | {{tp|p=32184201|t=2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists |pdf=|usr=}} | ||
+ | {{tp|p=32253225|t=2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases |pdf=|usr=}} | ||
+ | {{tp|p=32369736|t=ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes |pdf=|usr=}} | ||
Zeile 143: | Zeile 174: | ||
{{tp|p=32375200|t=2020. Pneumomediastinum following intubation in COVID-19 patients: a case series |pdf=|usr=}} | {{tp|p=32375200|t=2020. Pneumomediastinum following intubation in COVID-19 patients: a case series |pdf=|usr=}} | ||
{{tp|p=32304394|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report |pdf=|usr=}} | {{tp|p=32304394|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report |pdf=|usr=}} | ||
+ | {{tp|p=32371416|t=2020. Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection |pdf=|usr=}} | ||
+ | |||
+ | |||
*'''[[Case series]]''' | *'''[[Case series]]''' | ||
Zeile 155: | Zeile 189: | ||
*'''[[Trials]]''' | *'''[[Trials]]''' | ||
+ | {{tp|p=32245769|t=2020. Managing clinical trials for covid-19: the importance of ethics committees |pdf=|usr=}} | ||
+ | |||
*'''[[Candidate Compounds Covid19]]''' | *'''[[Candidate Compounds Covid19]]''' | ||
Zeile 180: | Zeile 216: | ||
{{tp|p=32312781|t=2020. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19 |pdf=|usr=}} | {{tp|p=32312781|t=2020. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19 |pdf=|usr=}} | ||
{{tp|p=32205349|t=2020. Updated Approaches against SARS-CoV-2 |pdf=|usr=}} | {{tp|p=32205349|t=2020. Updated Approaches against SARS-CoV-2 |pdf=|usr=}} | ||
+ | {{tp|p=32229155|t=2020. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?|pdf=|usr=}} | ||
+ | {{tp|p=32339387|t=2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin |pdf=|usr=}} | ||
+ | {{tp|p=32282033|t=2020. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32362106|t=2020. Management of conjunctivitis during the COVID-19 pandemic 2020 |pdf=|usr=}} | ||
+ | {{tp|p=32302379|t=2020. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients |pdf=|usr=}} | ||
+ | {{tp|p=32366511|t=2020. Developing a vaccine for covid-19 |pdf=|usr=}} | ||
+ | {{tp|p=32357949|t=2020. Covid-19: Remdesivir is helpful but not a wonder drug, say researchers |pdf=|usr=}} | ||
+ | {{tp|p=32217607|t=2020. Covid-19: what treatments are being investigated?|pdf=|usr=}} | ||
+ | {{tp|p=32217555|t=2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients |pdf=|usr=}} | ||
+ | {{tp|p=32209549|t=2020. Covid-19: trials of four potential treatments to generate "robust data" of what works |pdf=|usr=}} | ||
+ | {{tp|p=32340998|t=2020. Covid-19: What do we know so far about a vaccine?|pdf=|usr=}} | ||
+ | |||
Zeile 198: | Zeile 246: | ||
*'''[[Passive protective equipment]]''' | *'''[[Passive protective equipment]]''' | ||
{{tp|p=32352852|t=2020. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from Filtered Face Piece (FFP) masks during the coronavirus (COVID-19) pandemic |pdf=|usr=}} | {{tp|p=32352852|t=2020. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from Filtered Face Piece (FFP) masks during the coronavirus (COVID-19) pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32366499|t=2020. Covid-19: skin damage with prolonged wear of FFP3 masks |pdf=|usr=}} | ||
+ | {{ttp|p=32371574|t=2020. Facial protection for healthcare workers during pandemics: a scoping review |pdf=|usr=}} | ||
Zeile 210: | Zeile 260: | ||
{{tp|p=32219857|t=ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases |pdf=|usr=}} | {{tp|p=32219857|t=ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases |pdf=|usr=}} | ||
{{tp|p=32376399|t=ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}} | {{tp|p=32376399|t=ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |pdf=|usr=}} | ||
+ | {{tp|p=32376346|t=ä. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions |pdf=|usr=}} | ||
+ | {{tp|p=32369287|t=2020. COVID-19: GENERAL GUIDELINES FOR CARDIOVASCULAR SURGEONS (standard guidelines - subject to change) |pdf=|usr=}} | ||
+ | {{tp|p=32223063|t=ä. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab?specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID?19 |pdf=|usr=}} | ||
+ | {{tp|p=32361152|t=ä. The Use of Bronchoscopy During the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report |pdf=|usr=}} | ||
+ | {{tp|p=32253182|t=2020. Social distancing in covid-19: what are the mental health implications?|pdf=|usr=}} | ||
+ | {{tp|p=32345601|t=2020. Covid-19 makes the future of UK clinical research uncertain |pdf=|usr=}} | ||
+ | {{tp|p=32340996|t=2020. Managing patients with rheumatic conditions during the covid-19 pandemic |pdf=|usr=}} | ||
+ | |||
Zeile 226: | Zeile 284: | ||
*'''[[Occupational medicine, workplace security and status hygienicus]]''' | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | ||
− | + | {{tp|p=32366503|t=2020. Covid-19: NHS bosses told to assess risk to ethnic minority staff who may be at greater risk |pdf=|usr=}} | |
*'''[[Economic aspects of the status hygienicus]]''' | *'''[[Economic aspects of the status hygienicus]]''' | ||
*[https://www.weforum.org/agenda/2020/05/global-food-chains-disruption-covid19 global famine] | *[https://www.weforum.org/agenda/2020/05/global-food-chains-disruption-covid19 global famine] | ||
+ | {{tp|p=32366510|t=2020. Covid-19: collateral damage of lockdown in India |pdf=|usr=}} | ||
+ | {{tp|p=32253178|t=2020. Covid-19 and the rise of racism |pdf=|usr=}} | ||
+ | |||
Zeile 247: | Zeile 308: | ||
{{tp|p=32369541|t=ä. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review |pdf=|usr=}} | {{tp|p=32369541|t=ä. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review |pdf=|usr=}} | ||
{{tp|p=32267964|t=2020. Infection control in non-clinical areas during the COVID-19 pandemic |pdf=|usr=}} | {{tp|p=32267964|t=2020. Infection control in non-clinical areas during the COVID-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32271600|t=2020. Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review |pdf=|usr=}} | ||
+ | {{tp|p=32371381|t=2020. Covid-19: South Korea relaxes social distancing after the number of new cases drops below 10 a day |pdf=|usr=}} | ||
+ | {{tp|p=32376669|t=2020. Reducing risks from coronavirus transmission in the home-the role of viral load |pdf=|usr=}} | ||
+ | {{tp|p=32366374|t=2020. Covid-19: Deprived areas have the highest death rates in England and Wales |pdf=|usr=}} | ||
+ | {{tp|p=32217520|t=2020. The world s largest refugee camp prepares for covid-19 |pdf=|usr=}} | ||
+ | {{tp|p=32205334|t=2020. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village |pdf=|usr=}} | ||
+ | {{tp|p=32205309|t=2020. Covid-19: Highest risk patients are asked to stay at home for 12 weeks |pdf=|usr=}} | ||
+ | {{tp|p=32209548|t=2020. Covid-19: UK lockdown is "crucial" to saving lives, say doctors and scientists |pdf=|usr=}} | ||
+ | {{tp|p=32184206|t=2020. Covid-19: Doctors warn of humanitarian catastrophe at Europe s largest refugee camp |pdf=|usr=}} | ||
+ | {{tp|p=32265194|t=2020. Covid-19: Why Germany s case fatality rate seems so low |pdf=|usr=}} | ||
+ | {{tp|p=32368995|t=ä. Mental health and COVID-19: is the virus racist?|pdf=|usr=}} | ||
+ | {{tp|p=32345590|t=2020. Covid-19: undocumented migrants are probably at greatest risk |pdf=|usr=}} | ||
+ | |||
+ | |||
Zeile 256: | Zeile 331: | ||
*'''[[Failure of executive measures]]''' | *'''[[Failure of executive measures]]''' | ||
{{tp|p=32324421|t=2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health |pdf=|usr=}} | {{tp|p=32324421|t=2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health |pdf=|usr=}} | ||
− | + | {{tp|p=32366370|t=2020. Covid-19: Coroners needn t investigate PPE policy failures in deaths of NHS staff, new guidance says |pdf=|usr=}} | |
---- | ---- | ||
*'''[[Failure of politics and public health guidance]]''' | *'''[[Failure of politics and public health guidance]]''' | ||
{{tp|p=32358933|t=2020. Lessons from the USA Delayed Response to the COVID-19 Pandemic |pdf=|usr=}} | {{tp|p=32358933|t=2020. Lessons from the USA Delayed Response to the COVID-19 Pandemic |pdf=|usr=}} | ||
− | + | {{tp|p=32144176|t=2020. Trump claims public health warnings on covid-19 are a conspiracy against him |pdf=|usr=}} | |
+ | {{tp|p=32224494|t=2020. Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest |pdf=|usr=}} | ||
+ | {{tp|p=32205354|t=2020. Clinical trials suspended in UK to prioritise covid-19 studies and free up staff |pdf=|usr=}} | ||
+ | {{tp|p=32107254|t=2020. Covid-19: Trump says risk to Americans is "very low" |pdf=|usr=}} | ||
*'''[[Political abuse of Covid19]]''' | *'''[[Political abuse of Covid19]]''' | ||
{{tp|p=32227594|t=ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic |pdf=|usr=}} | {{tp|p=32227594|t=ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32213480|t=2020. Covid-19: how to be careful with trust and expertise on social media |pdf=|usr=}} | ||
+ | |||
*'''[[Lost people]]''' | *'''[[Lost people]]''' | ||
Zeile 275: | Zeile 355: | ||
*'''[[History of covid19 exploration]]''' | *'''[[History of covid19 exploration]]''' | ||
{{tp|p=32271601|t=2020. Epidemiology and Clinical Characteristics of COVID-19 |pdf=|usr=}} | {{tp|p=32271601|t=2020. Epidemiology and Clinical Characteristics of COVID-19 |pdf=|usr=}} | ||
+ | {{tp|p=32144096|t=2020. Covid-19: UK records first death, as world s cases exceed 100 000 |pdf=|usr=}} | ||
+ | {{tp|p=32165426|t=2020. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction |pdf=|usr=}} | ||
+ | {{tp|p=32071063|t=2020. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate |pdf=|usr=}} | ||
+ | {{tp|p=32273278|t=2020. Covid-19: should the public wear face masks?|pdf=|usr=}} | ||
+ | {{tp|p=32273267|t=2020. Face masks for the public during the covid-19 crisis |pdf=|usr=}} | ||
+ | {{tp|p=32265341|t=2020. Covid-19: What is the evidence for cloth masks?|pdf=|usr=}} | ||
+ | {{tp|p=32354787|t=2020. A third of covid-19 patients admitted to UK hospitals die |pdf=|usr=}} | ||
+ | {{tp|p=32327412|t=2020. Covid-19: Two thirds of healthcare workers who have died were from ethnic minorities |pdf=|usr=}} | ||
+ | |||
+ | *'''[[misc.]]''' | ||
+ | {{tp|p=32220929|t=2020. Guidance needed for singlehanded GPs to deal with covid-19 pandemic |pdf=|usr=}} | ||
+ | {{tp|p=32205317|t=2020. Covid-19: give NHS staff rest spaces and free parking not thank yous, says doctor |pdf=|usr=}} | ||
+ | {{tp|p=32349824|t=ä. The COVID-19 Pandemic: A Month of Bioethics in Finland |pdf=|usr=}} | ||
+ | {{tp|p=32327407|t=2020. Covid-19: BMA demands full death in service benefits for UK doctors |pdf=|usr=}} | ||
− | |||
*'''[[Research tools]]''' | *'''[[Research tools]]''' | ||
Version vom 31. Mai 2020, 13:16 Uhr
32327431 2020. Keeping up with studies on covid-19: systematic search strategies and resources
32202343 ä. Systematic review of COVID?19 in children shows milder cases and a better prognosis than adults
32196678 ä. Eleven faces of coronavirus disease 2019
32363707 2020. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review
32253003 2020. COVID-19 virus and children: What do we know?
32279352 2020. Blood and blood product use during COVID-19 infection
32223716 2020. Diagnosis and Management of COVID-19 Disease
32221973 2020. The Italian coronavirus disease 2019 outbreak: recommendations from clinical practice
32189015 2020. "Coronavirus disease 2019" (COVID-19): update fur Anasthesisten und Intensivmediziner Marz 2020
32330073 2020. COVID-19 Lung Injury and High Altitude Pulmonary Edema: A False Equation with Dangerous Implications |
32319081 2020. Delivering extracorporeal membrane oxygenation for patients with COVID-19: what, who, when and how?
32358233 2020. Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers |
32341294 2020. Toward Precision Delivery of Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019 Cardiorespiratory Failure
32317557 2020. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in Coronavirus Disease 2019: Experience with 32 Patients
32243267 2020. Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure
32243266 2020. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China
32366375 2020. Management of respiratory failure due to covid-19
32229575 2020. Covid-19: Mercedes F1 to provide breathing aid as alternative to ventilator
32377387 2020. High-flow Nasal Cannula Oxygenation Revisited in COVID-19
32293905 2020. SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients
32338536 2020. A Bayesian analysis of strategies to rule out COVID19 using reverse transcriptase-polymerase chain reaction (RT-PCR)
32294808 2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology)
32275766 2020. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review
32298464 2020. Whole body point-care ultrasound for COVID-19: a multi-system approach to a multi-system disease
32357307 2020. Radiographic examination of the chest and COVID-19
32271603 2020. Dynamic Chest CT Evaluation in Three Cases of 2019 Novel Coronavirus Pneumonia
32348474 2020. Expanding our understanding of the role polyprotein conformation plays in the coronavirus life cycle
32369402 2020. ANNALS EXPRESS: Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: a closer look at angiotensin-converting enzyme 2 (ACE2)
32378705 2020. A virus that has gone viral: amino acid mutation in S protein of Indian isolate of Coronavirus COVID-19 might impact receptor binding, and thus, infectivity
32376393 ä. Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |
32220633 2020. Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?
32376400 ä. Cytokine storm syndrome in severe COVID-19 |
32376401 ä. Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? |
32293098 2020. On the Alert for Cytokine Storm: Immunopathology in COVID-19
32339387 2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
32345602 2020. Covid-19: concerns grow over inflammatory syndrome emerging in children
32379417 ä. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age
32376402 ä. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies |
32361194 ä. Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons |
32323565 2020. Is Low Alveolar Type II Cell SOD3 in the Lungs of Elderly Linked to the Observed Severity of COVID-19? |
32348692 2020. COVID-19 Related Genes in Sputum Cells in Asthma: Relationship to Demographic Features and Corticosteroids
32374218 2020. Avian coronaviruses
32173883 ä. COVID?19 and mycoplasma pneumoniae coinfection
32314699 2020. Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic
32271596 2020. Co-infection of Coronavirus Disease 2019 and Influenza A: A Report from Iran
32374823 2020. COVID-2019 associated overexpressed Prevotella proteins mediated host-pathogen interactions and their role in coronavirus outbreak |
32339221 2020. COVID-19 and its implications for thrombosis and anticoagulation
32255359 2020. Clinical utility of cardiac troponin measurement in COVID-19 infection
32327427 2020. Myositis as a manifestation of SARS-CoV-2
32374032 2020. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2 - exploring RAS inhibitors
32302212 2020. COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation
32376320 ä. Severe acute respiratory syndrome coronavirus 2 detection in the female lower genital tract
32320102 ä. Hydatidiform mole in the era of COVID?19 pandemic Is there an association?
32266828 2020. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19)
32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
32241792 2020. COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
32354772 2020. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept
32332075 2020. Patients with lupus are not protected from COVID-19
32332072 2020. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine
32295789 2020. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19
32327426 2020. SLE patients are not immune to covid-19: importance of sending the right message across
32295787 2020. SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment
32321720 2020. Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)
32312768 2020. Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
32245656 2020. COVID-19 in patients with cardiovascular diseases
32180426 2020. An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes
32255510 2020. COVID-19 and the use of immunomodulatory and biologic agents for severe cutaneous disease: An Australian/New Zealand consensus statement
32369656 2020. Coronavirus disease 2019 among pregnant Chinese women: case series data on the safety of vaginal birth and breastfeeding
32219995 2020. Safe delivery for pregnancies affected by COVID-19
32339382 2020. Vaginal delivery in SARS-CoV-2-infected pregnant women in Northern Italy: a retrospective analysis
32324956 2020. How should we treat pregnant women infected with SARS-CoV-2?
32340018 2020. Coronavirus Disease 2019 in a Hemodialysis Patient
32220865 2020. Non-steroidal anti-inflammatory drugs and covid-19
32205306 2020. Covid-19: European drugs agency to review safety of ibuprofen
32184201 2020. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
32253225 2020. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases
32369736 ä. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
32364491 ä. Are COVID-19 survivors at increased risk for suicide?
32282359 2020. Rehabilitation After Critical Illness in People With COVID-19 Infection
32277694 2020. Case Report: Death Due to Novel Coronavirus Disease (COVID-19) in Three Brothers
32375200 2020. Pneumomediastinum following intubation in COVID-19 patients: a case series
32304394 2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report
32371416 2020. Family cluster of three recovered cases of pneumonia due to severe acute respiratory syndrome coronavirus 2 infection
32255382 2020. Hospitalization and Critical Care of 109 Decedents with COVID-19 Pneumonia in Wuhan, China
32245769 2020. Managing clinical trials for covid-19: the importance of ethics committees
32329159 2020. Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach
32376597 2020. Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
32345616 2020. Anti-inflammatory therapy may ameliorate the clinical picture of COVID-19
32304395 2020. COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support
32349115 ä. Chloroquine and Hydroxychloroquine Retinal Toxicity Consideration in the Treatment of COVID-19 |
32380318 ä. Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection
32380316 ä. Convalescent plasma in Covid-19: Possible mechanisms of action
32380315 ä. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32376396 ä. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
32376395 ä. SARS-CoV-2 infection among patients with systemic autoimmune diseases
32376392 ä. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
32376403 ä. Imatinib might constitute a treatment option for lung involvement in COVID-19
32376394 ä. Immunomodulatory therapy for the management of severe COVID-19 Beyond the anti-viral therapy: A comprehensive review |
32376397 ä. Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view |
32376398 ä. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
32361195 ä. SARS-CoV-2 infection complicated by inflammatory syndrome Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
32304139 ä. Progress and Concept for COVID?19 Vaccine Development
32213152 2020. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
32299796 2020. Antirheumatic agents in covid-19: is IL-6 the right target?
32376613 2020. Inhibition of SARS-CoV-2 infection by the cyclophilin inhibitor Alisporivir (Debio 025) |
32366720 2020. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
32312781 2020. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
32205349 2020. Updated Approaches against SARS-CoV-2
32229155 2020. Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
32339387 2020. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
32282033 2020. Initiating adjunct low-dose hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic
32362106 2020. Management of conjunctivitis during the COVID-19 pandemic 2020
32302379 2020. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients
32366511 2020. Developing a vaccine for covid-19
32357949 2020. Covid-19: Remdesivir is helpful but not a wonder drug, say researchers
32217607 2020. Covid-19: what treatments are being investigated?
32217555 2020. Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
32209549 2020. Covid-19: trials of four potential treatments to generate "robust data" of what works
32340998 2020. Covid-19: What do we know so far about a vaccine?
32189463 ä. The possibility of COVID?19 transmission from eye to nose
32189460 ä. There may be virus in conjunctival secretion of patients with COVID?19
32352852 2020. Hydrocolloid dressing strip over bridge of nose to relieve pain and pressure from Filtered Face Piece (FFP) masks during the coronavirus (COVID-19) pandemic
32366499 2020. Covid-19: skin damage with prolonged wear of FFP3 masks
32371574 2020. Facial protection for healthcare workers during pandemics: a scoping review |
32311772 2020. Intubation boxes for managing the airway in patients with COVID-19
32311771 2020. Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review |
32324055 2020. A safe method to evacuate pneumoperitoneum during laparoscopic surgery in suspected COVID-19 patients
32380058 ä. Safe Reintroduction of Cardiovascular Services during the COVID-19 Pandemic: Guidance from North American Society Leadership
32379080 2020. Protecting Surgical Teams During the COVID-19 Outbreak: A Narrative Review and Clinical Considerations |
32345617 2020. Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey
32345619 2020. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic
32219857 ä. Advice regarding COVID?19 and use of immunomodulators, in patients with severe dermatological diseases
32376399 ä. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion
32376346 ä. An In-hospital Pathway for Acute Coronary Syndrome Patients During the COVID-19 Outbreak: Initial Experience under Real-world Suboptimal Conditions
32369287 2020. COVID-19: GENERAL GUIDELINES FOR CARDIOVASCULAR SURGEONS (standard guidelines - subject to change)
32223063 ä. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab?specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID?19
32361152 ä. The Use of Bronchoscopy During the COVID-19 Pandemic: CHEST/AABIP Guideline and Expert Panel Report
32253182 2020. Social distancing in covid-19: what are the mental health implications?
32345601 2020. Covid-19 makes the future of UK clinical research uncertain
32340996 2020. Managing patients with rheumatic conditions during the covid-19 pandemic
32376695 2020. Where have all the children gone? Decreases in paediatric emergency department attendances at the start of the COVID-19 pandemic of 2020
32366503 2020. Covid-19: NHS bosses told to assess risk to ethnic minority staff who may be at greater risk
32366510 2020. Covid-19: collateral damage of lockdown in India
32253178 2020. Covid-19 and the rise of racism
32196426 2020. Seasonality of Respiratory Viral Infections
32298494 2020. The role of children in the transmission of mild SARS-CoV-2 infection
32369541 ä. Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers: A Living Rapid Review
32267964 2020. Infection control in non-clinical areas during the COVID-19 pandemic
32271600 2020. Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review
32371381 2020. Covid-19: South Korea relaxes social distancing after the number of new cases drops below 10 a day
32376669 2020. Reducing risks from coronavirus transmission in the home-the role of viral load
32366374 2020. Covid-19: Deprived areas have the highest death rates in England and Wales
32217520 2020. The world s largest refugee camp prepares for covid-19
32205334 2020. Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village
32205309 2020. Covid-19: Highest risk patients are asked to stay at home for 12 weeks
32209548 2020. Covid-19: UK lockdown is "crucial" to saving lives, say doctors and scientists
32184206 2020. Covid-19: Doctors warn of humanitarian catastrophe at Europe s largest refugee camp
32265194 2020. Covid-19: Why Germany s case fatality rate seems so low
32368995 ä. Mental health and COVID-19: is the virus racist?
32345590 2020. Covid-19: undocumented migrants are probably at greatest risk
32366742 ä. Prolonged Viral RNA Shedding Duration in COVID-19
32342849 2020. Case Report: Viral Shedding for 60 Days in a Woman with Novel Coronavirus Disease (COVID-19)
32324421 2020. Raids on Immigrant Communities During the Pandemic Threaten the Country s Public Health
32366370 2020. Covid-19: Coroners needn t investigate PPE policy failures in deaths of NHS staff, new guidance says
32358933 2020. Lessons from the USA Delayed Response to the COVID-19 Pandemic
32144176 2020. Trump claims public health warnings on covid-19 are a conspiracy against him
32224494 2020. Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest
32205354 2020. Clinical trials suspended in UK to prioritise covid-19 studies and free up staff
32107254 2020. Covid-19: Trump says risk to Americans is "very low"
32227594 ä. Social media for rapid knowledge dissemination: early experience from the COVID?19 pandemic
32213480 2020. Covid-19: how to be careful with trust and expertise on social media
32271601 2020. Epidemiology and Clinical Characteristics of COVID-19
32144096 2020. Covid-19: UK records first death, as world s cases exceed 100 000
32165426 2020. Covid-19: WHO declares pandemic because of "alarming levels" of spread, severity, and inaction
32071063 2020. Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
32273278 2020. Covid-19: should the public wear face masks?
32273267 2020. Face masks for the public during the covid-19 crisis
32265341 2020. Covid-19: What is the evidence for cloth masks?
32354787 2020. A third of covid-19 patients admitted to UK hospitals die
32327412 2020. Covid-19: Two thirds of healthcare workers who have died were from ethnic minorities
32220929 2020. Guidance needed for singlehanded GPs to deal with covid-19 pandemic
32205317 2020. Covid-19: give NHS staff rest spaces and free parking not thank yous, says doctor
32349824 ä. The COVID-19 Pandemic: A Month of Bioethics in Finland
32327407 2020. Covid-19: BMA demands full death in service benefits for UK doctors